Rohrberg KS, Olesen RK, Pfeiffer P, Ladekarl M, Pappot H, Christensen IJ, et al. Phase II trial of erlotinib and bevacizumab in patients with advanced upper gastrointestinal cancers. AO [Internet]. 2012 Feb. 1 [cited 2026 May 18];51(2):234-42. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/30634